Mavacamten 1642288-47-8 pharmaceutical grade high-purity 99% in stock
COA 10 Inquiries
1642288-47-8
pharmaceutical grade
99%
shanghai
Ipure
25kg/Cardboard Drum
Yes
2026-01-25
pharmaceutical intermediates,chemical
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceMavacamten is under investigation in clinical trial NCT03442764 (A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)).
Mavacamten(MYK-461)is a first-in-class allosteric inhibitor of cardiac myosin that promises to provide clinicians with targeted therapy for these patients. It is a mechanistically novel small molecule that acts on the sarcolemma to specifically inhibit contractility and has been proposed as a treatment for HCM.CertificatesBasic Info-
Product Name:
Mavacamten
Other Name:MYK-461 (SAR-439152);SAR 439152;SAR439152;SAR-439152;SAR-439152; SAR 439152; SAR439152; MYK-461; MYK 461; MYK461; MAVACAMTEN;MYK-461 - Mavacamten | SAR439152;Mavacamten (MYK-461;6-([(1S)-1-phenylethyl]amino)-3-(propan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione
CAS No.:1642288-47-8
Molecular Formula:C15H19N3O2
InChIKeys:RLCLASQCAPXVLM-NSHDSACASA-N
Molecular Weight:273.33
Exact Mass:273.147726857
EC Number:213-161-7
UNII:QX45B99R3J
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.19±0.1 g/cm3(Predicted)
PKA:8.83±0.40(Predicted)
Critical Temperature & Pressure:Storage temp. -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
pharmaceutical intermediates,chemical
-
Location:
Company Office Address: Room 1508, 15/F, Yate Centre Office Tower 2, 625 Nathan Road, Mong Kok, Hong Kong
-
Payment Terms:
TT against copy of documents,D/P,L/C,O/A,100% TT in advance
-
Average lead Time:
10 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2025
-
-
Inquiry History10 Inquiries
Country Product Purchase Quantity Date Posted
India
Mavacamten
10.00 MT Jan 22, 2024
India
MAVACAMTEN API POWDER
25.00 KG Feb 29, 2024
India
MAVACAMTEN
25 KG Feb 28, 2024
Russia
Mavacamten
100 G Mar 31, 2025
Australia
Mavacamten
1 MT May 15, 2025
India
Mavacamten
1.00 KG Mar 7, 2024
India
URSODEOXYCHOLIC ACID
10.00 KG Mar 6, 2024
India
Acarbose
10.00 KG Mar 6, 2024
India
Upadacitinib
10.00 KG Mar 6, 2024
India
Ripretinib
10.00 KG Mar 6, 2024 Post an enquiry for this product
More from this Seller
-
-
-
2-bromo-3-methylpropiophenone 1451-83-8
pharmaceutical grade / 99%
-
-
-
-
Elagolix sodium 832720-36-2 in stocks
Pharmaceutical Grade / 99%
-
-
-
-
2226664-93-1KY19382
pharmaceutical grade / 99%
-
-
-
-
Purple 47 81-63-0 pharmaceutical grade high-purity 99% in stock
pharmaceutical grade / 99%
-
-
-
-
2-Methyl anthraquinone .smoke white .high purity 98%.top quality
Pharmaceutical Grade / 98%
-
-
-
-
Nefiracetam 77191-36-7 Top quality in stocks
pharmaceutical grade / 99%
-